Cargando…
Live, Genetically Attenuated, Cold-Chain-Free Cholera Vaccine—A Research and Development Journey: Light at the End of a Long Tunnel
Cholera, a diarrheal disease caused by Vibrio cholerae (V. cholerae) O139 and O1 strains, remains a public health problem. The existing World Health Organization (WHO)-licenced, killed, multiple-dose oral cholera vaccines demand ‘cold-chain supply’ at 2 °C–8 °C. Therefore, a live, single-dose, cold-...
Autores principales: | RAVICHANDRAN, Manickam, TEW, Hui Xian, PRABHAKARAN, Guruswamy, PARASURAMAN, Subramani, NORAZMI, Mohd Nor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Penerbit Universiti Sains Malaysia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036929/ https://www.ncbi.nlm.nih.gov/pubmed/35528817 http://dx.doi.org/10.21315/mjms2022.29.2.1 |
Ejemplares similares
-
Dual-Use Vaccine for Diarrhoeal Diseases: Cross-Protective Immunogenicity of a Cold-Chain-Free, Live-Attenuated, Oral Cholera Vaccine against Enterotoxigenic Escherichia coli (ETEC) Challenge in BALB/c Mice
por: Hui Xian, Tew, et al.
Publicado: (2022) -
Immunogenicity and protective efficacy of a live, oral cholera vaccine formulation stored outside-the-cold-chain for 140 days
por: Xian, Tew Hui, et al.
Publicado: (2020) -
Construction and Evaluation of V. cholerae O139 Mutant, VCUSM21P, as a Safe Live Attenuated Cholera Vaccine
por: Murugaiah, Chandrika, et al.
Publicado: (2014) -
Structural inferences for Cholera toxin mutations in Vibrio cholerae
por: Shamini, Gunasagaran, et al.
Publicado: (2011) -
Immunometabolism of Immune Cells in Mucosal Environment Drives Effector Responses against Mycobacterium tuberculosis
por: Tukiman, Mohd Hatimi, et al.
Publicado: (2022)